MarketReports DNA Vaccine Market Size Analysis, Segmentation, In | Page 2

which is expected to fuel market demand for DNA vaccine over the forecast period. Rising influence of
commercialization and digitalization in healthcare sector are driving the demand for DNA vaccine, in the recent years.
DNA vaccine helps to protect against disease with the help of genetically engineered DNA that are capable of producing
various antigens and protective immunological response in the human and animal’s body. DNA vaccines offers
numerous advantages over the conventional vaccines due to their wider range of immune response types. These factors
are expected to pave the way for future market growth of DNA vaccines. Increasing demand for DNA vaccines for
veterinary use is projected to foster market growth over the forecast period.
Current DNA vaccines are referred as third generation vaccines as they consist of DNA that codes for specific proteins
or antigens from a given pathogen. These DNA are injected into the animal or human body, which is then taken up by
cells. Such cells undergo normal metabolic processes and synthesize proteins based on the genetic code in the plasmid.
This process triggers immune responses in the patient. These factors are propelling the demand for DNA vaccines to
boost immune response of the animal or human body.
Get a Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/dna-vaccine-market-
insights/request-sample
The market is broadly categorized into two major segments based on the application type such as human DNA vaccines
and animal DNA vaccines. The animal DNA vaccines is considered as one of the fastest growing segment in the DNA
vaccine market with substantial revenue generation in the last few years.
Growing popularity of the animal DNA vaccines segment is attributed to the higher approval rate and current
development in the field of DNA synthesis, immunology and molecular biology. The human DNA vaccines segment
has also witnessed substantial growth due to increase in investment by private and government authorities in research
& development activities across the globe.
The market is divided by region as North America, Europe, Asia-Pacific, Latin America and Africa. North America has
shown major growth in recent years owing to the rise in the implementation of latest technologies in medicine &
pharmaceutical industry, prevalence of genetic diseases, increase in the number of research & development activities
and existence of well-established healthcare infrastructure in the region.
Asia-Pacific region is predicted to hold major market share in the DNA vaccine market with massive growth in forecast
period. Countries such as India, China and Singapore are leading the Asia-Pacific market with strong economic growth
in the region, ever-growing geriatric population, increasing healthcare expenditure, and significant investment by
leading industry players considering potential growth opportunities in the region.
The key players in the DNA vaccine market are Arbutus Biopharma Co., Sanofi S.A., Vical Ltd., Astellas Pharma, Inc.,
Dendreon Co., Merck & Co., Invio Biomedical, Inc., and Novartis Animal Health, Inc.
Browse Full Research Report @ https://www.millioninsights.com/industry-reports/dna-vaccine-market-insights